Systemic infection induces conserved physiological responses that include both resistance and 'tolerance of infection' mechanisms 1 . Temporary anorexia associated with an infection is often beneficial 2,3 , reallocating energy from food foraging towards resistance to infection 4 or depriving pathogens of nutrients 5 . However, it imposes a stress on intestinal commensals, as they also experience reduced substrate availability; this affects host fitness owing to the loss of caloric intake and colonization resistance (protection from additional infections) 6 . We hypothesized that the host might utilize internal resources to support the gut microbiota during the acute phase of the disease. Here we show that systemic exposure to Toll-like receptor (TLR) ligands causes rapid a(1,2)-fucosylation of small intestine epithelial cells (IECs) in mice, which requires the sensing of TLR agonists, as well as the production of interleukin (IL)-23 by dendritic cells, activation of innate lymphoid cells and expression of fucosyltransferase 2 (Fut2) by IL-22-stimulated IECs. Fucosylated proteins are shed into the lumen and fucose is liberated and metabolized by the gut microbiota, as shown by reporter bacteria and community-wide analysis of microbial gene expression. Fucose affects the expression of microbial metabolic pathways and reduces the expression of bacterial virulence genes. It also improves host tolerance of the mild pathogen Citrobacter rodentium. Thus, rapid IEC fucosylation appears to be a protective mechanism that utilizes the host's resources to maintain host-microbial interactions during pathogen-induced stress.
To maintain healthy gut microbiota during a systemic response induced by microbial products the host may use its internal resources. L-Fucosylation could present an example of such a resource: L-fucose attached to glycoproteins and glycolipids is accessible for microbial, but not for host energy harvest 7, 8 . Constitutive a(1,2)fucosylation affects the microbial community in a diet-dependent manner 9 , serves as a substrate for pathogens during antibiotic exposure 10 and for microbes colonizing the ileum of newborns or of adult germ-free (GF) mice [11] [12] [13] . Under normal conditions, however, the small intestine of specific pathogen-free (SPF) BALB/c mice is largely free of surface fucose. By contrast, a systemic injection of agonists of TLRs, such as lipopolysaccharide (LPS; TLR4 ligand) ( Fig. 1 ), CpG DNA (TLR9 ligand), or Pam 3 CSK 4 (TLR2 agonist), led to ubiquitous a(1,2)fucosylation of the small intestine in mice of different genetic backgrounds, which started within a few hours after LPS exposure and lasted for several days (Extended Data Fig. 1a-c) . It did not result in differentiation of IECs into functional M cells 14 , which are permanently fucosylated and are involved in microbial sensing and translocation (Extended Data Fig. 1d ). Induced fucosylation was independent of the gut microbiota (observed in GF mice), and was not induced by oral LPS (Extended Data Fig. 1e ).
Global deletion of the TLR signalling adaptor molecule MyD88 prevented IEC fucosylation, and its conditional deletion from dendritic cells, but not from IECs, abrogated the process (Fig. 1) . The inducible fucosylation pathway was similar to induction of antimicrobial peptides by a systemic microbial signal 15 : it required MyD88-expressing dendritic cells, production of IL-23, the transcriptional regulator RORct and IL-22 ( Fig. 1 and Extended Data Fig. 2a ), and was induced by a direct injection of IL-22 into Myd88 2/2 mice (Fig. 1 ). IEC fucosylation in mice lacking T cells ( Fig. 1) suggested that innate lymphoid cells (ILCs) were a sufficient source of IL-22. Salmonella enterica ssp. Typhimurium, known to spread systemically, induced small intestine IEC fucosylation (Extended Data Fig. 2b ). The a(1,2)fucosyltransferase responsible for fucosylation of IECs in the small intestine was identified as Fut2 ( Fig. 2a ), which is inducible by stress conditions 16, 17 and constitutively expressed in the stomach and large intestine 18 . Genetic ablation of the Fut2 gene blocked IEC fucosylation in response to LPS (Fig. 2b, c) . The overall chain of events is shown in Extended Data Fig. 3 .
LPS injection caused marked sickness in BALB/c Fut2-deficient (Fut2 2/2 ) and Fut2-sufficient (Fut2 1/1 or Fut2 1/2 ) littermates hours after injection: mice displayed measurable anorexia, adipsia, reduced activity, diarrhoea and weight loss. Food consumption, weight loss, and production of inflammatory cytokines and antimicrobial peptides ( Fig. 2d , e and Extended Data Fig. 4a , b) were similar in both groups. Although systemic stimulation of TLRs. UEA-1, which binds a(1,2)-fucosylated substrates, staining in the proximal one-third of the small intestine of mice untreated or 24 h after intraperitoneal (i.p.) LPS injection, or 6 h after injection of IL-22 (Myd88 2/2 mouse). Scale bars 5 100 mm. Staining of tissue from mutant mice was always accompanied by staining of wild-type (WT) controls, and is representative of at least two independent experiments for each genotype. Fut2 2/2 mice have been shown to be healthy under normal SPF conditions 19 , they were significantly slower than controls in recovering their body weight ( Fig. 2e ) after LPS injection. Importantly, food deprivation without LPS challenge did not cause small intestine fucosylation and the weight recovery was identical in Fut2-sufficient and Fut2-deficient animals (Extended Data Figs 1a and 4c). Thus, fucosylation of the small intestine was a response to activation by microbial stimuli and not to anorexia per se.
To understand the reason for the slow weight recovery in Fut2 2/2 mice, we tested whether fucosylation affected the function of host IEC proteins, which were identified by direct sequencing as secreted mucins and digestive enzymes ( Fig. 3a ). Fucosylation did not change the activity of several enzymes (Fig. 3b ). Thus, changes in enzymatic activity are unlikely to explain the slow weight recovery in Fut2 2/2 mice, although the role of less abundant fucosylated proteins cannot be excluded.
The beneficial effect of fucosylation was dependent on the microbiota: the weight recovery after LPS challenge was delayed in GF mice and in wild-type SPF mice treated with antibiotics ( Fig. 2e ). Antibiotics did not have a direct effect on the host's responses to LPS (Extended Data Fig. 4a , b, d-g) and did not further impair the recovery of Fut2 2/2 mice ( Fig. 2e ). Thus, Fut2 and an intact gut microbiota were both necessary for efficient recovery of body weight after LPS challenge.
To serve as a substrate to the bacteria residing in the large intestine 20 , fucosylated proteins (Extended Data Fig. 5a -d) must be released into the small intestine lumen. After LPS challenge, Fut2-dependent fucosylation of luminal proteins was detectable at much higher levels in GF mice and in SPF mice treated with antibiotics or with a fucosidase inhibitor, than in SPF controls ( Fig. 3c and Extended Data Fig. 5e ). Thus, fucose is available, released and used by microbes in the large intestine.
Next, to directly show fucose sensing by intestinal commensal bacteria, we used a reporter system in which Escherichia coli expressed green fluorescent protein (GFP) driven by the promoter of the E. coli fucose metabolism operon 21, 22 (Fig. 3d , e and Extended Data Fig. 6a ). Because E. coli lacks a(1,2)fucosidase that cleaves fucose off substrates, in GF mice monocolonized with the reporter E. coli it did not upregulate GFP, even after LPS injection ( Fig. 3d ). Thus, free fucose was not readily available for reporter bacteria in the gut and required bacterial fucosidase activity, which was sensitive to antibiotics (Extended Data Fig. 6b ). A commensal bacterium with a(1,2)fucosidase activity, Bacteroides acidifaciens, was isolated from our mouse colony (Extended Data Fig. 6c-e ). In LPS-injected GF mice co-colonized with the reporter E. coli and B. acidifaciens, the reporter strain expressed significantly more GFP (Fig. 3d) , as well as genes for fucose import (fucP) and metabolism (fucA) (Fig. 3f ). In LPS-treated SPF mice, Fut2 was required for GFP reporter expression ( Fig. 3e and Extended Data Fig. 6f ). These findings made it clear that fucose can serve as a substrate for the microbiota under conditions of stress applied to the host, and underscored the interdependence between members of the gut microbial community 23 .
To confirm these findings in mice with complex gut microbiota, we profiled microbial community structure, gene abundance and transcriptional activity before and after LPS treatment of Fut2 1/2 and Fut2 2/2 mice (Supplementary Table 1 ). Analyses of community structure based on 16S and shotgun DNA sequencing revealed that the gut microbiota was largely robust to host genotype and LPS exposure ( Fig. 3g and Extended Data Fig. 7a, b ). We did not detect: (1) significant clustering of microbial communities based on genotype or LPS treatment (P . 0.05 for both comparisons; permutational multivariate analysis of variance (PERMANOVA) of unweighted UniFrac distances); (2) species-level operational taxonomic units (OTUs) significantly associated with host genotype before or after LPS treatment (all were q . 0.05; analysis of variance (ANOVA)); or (3) significant differences in overall microbial diversity (Extended Data Fig. 7c ). However, we were able to detect a significantly increased abundance of B. acidifaciens after LPS treatment in Fut2-sufficient mice (P , 0.05, linear discriminant analysis (LDA) score . 4; linear discriminant analysis effect size (LefSe) analysis of 16S profiles), consistent with its ability to utilize fucosylated glycans.
At the same time, LPS markedly altered community-wide gene expression in both Fut2 1/2 and Fut2 2/2 mice ( Fig. 3h) , with multiple orthologous groups differentially expressed upon LPS treatment: 61 in Fut2 1/2 mice and 56 in Fut2 2/2 animals. These changes were not due to altered community structure: only one differentially expressed orthologous group (K05351, xylulose reductase) also exhibited significant changes in gene abundance (Supplementary Table 2 ). As expected, we detected a significant upregulation of fucose permease (fucP; K02429) in Fut2-sufficient mice after exposure to LPS (Fig. 3i ), and increased expression of metabolic modules for anaerobic respiration, protein and ATP synthesis, isoprenoid biosynthesis and amino sugar import, in addition to pathways 
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for aminoglycan degradation (Extended Data Fig. 7d ). Thus, intact host fucosylation appears to affect gut microbial metabolism. Importantly, LPS challenge led to the significantly increased expression of microbial virulence genes in Fut2-negative but not Fut2-sufficient mice, including rtxA (K10953) and haemolysin III (K11068) (Supplementary Table 2 ). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways potentially involved in microbial pathogenesis (defined as flagellar synthesis, chemotaxis, plant/pathogen interaction and Vibrio cholera infection) were overrepresented in Fut2-deficient mice (Extended Data Fig. 7d ). We hypothesized that fucosylation induced by systemic microbial challenge might limit the effects of additional exogenous or endogenous pathogens. We tested this by infecting Fut2-sufficient and Fut2-deficient mice with a non-lethal intestinal pathogen, C. rodentium. Four days after infection, mice were treated with LPS. Infected Fut2-negative mice lost significantly more weight than Fut2-sufficient animals compared with respective LPS-treated non-infected controls (Fig. 4a ). Thus, infection with a non-lethal pathogen further reduced the overall fitness of Fut2deficient mice in response to LPS. C. rodentium did not induce small intestine IEC fucosylation and did not colonize the small intestine (Extended Data Fig. 8 ), indicating that systemic challenge by a microbial product was required to reveal the role of inducible fucosylation.
The fitness of infected animals can be maintained through either decreased pathogen burden (resistance), or by an increase in pathogen tolerance without a change in pathogen burden. We quantified the abundance of C. rodentium in the faeces of infected mice, as well as the adherence to IECs of C. rodentium-expressing luciferase 24, 25 (Fig. 4b, c ). No differences in pathogen loads were found between Fut2-sufficient and Fut2deficient animals treated with LPS. Thus, fucosylation of the small intestine upon systemic treatment with LPS probably enhances tolerance of the pathogen. Fut2-negative mice infected with C. rodentium and injected with LPS had more pronounced colonic hyperplasia (a trademark of this infection) compared with Fut2-sufficient mice or mice that did not receive LPS ( Fig. 4d, e ).
Thus, inducible IEC fucosylation might be viewed as an emergency measure taken by the host to support its gut commensals. Fucose used by microbes as an energy source may contribute to protection of the host from endogenous opportunistic pathogens, or it could increase tolerance of infection by regulating bacterial genes responsible for quorum sensing 26 or virulence 27 . Fucose can also serve as a substrate for microbial production of the short-chain fatty acid propionate (Extended Data Fig. 9 ), which is primarily produced by members of the Bacteroidetes phylum 28 . Whether this process contributes to overall fitness of the animals under infection-induced stress remains to be elucidated. Of note, around 20% of humans lack a functional FUT2 gene, which is linked to Crohn's disease 29 and to lethality from sepsis in premature infants 30 . Overall, fucosylation of the small intestine in response to systemic microbial exposure can be considered a type of 'tolerance of infection' response. It is interesting, however, that a very similar pathway regulates secretion of antimicrobial Fut2 Table 2 for complete list). i, Increased gut microbial expression of fucP (K02429) in Fut2-sufficient mice (mean 6 s.e.m.; *P , 0.01, Mann-Whitney test).
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proteins-a resistance mechanism 15 . Thus, the mechanisms of resistance and tolerance to pathogens could be evolutionarily linked together to increase the fitness of the host.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Mice. BALB/cJ, C57BL/6J, NOD/LtJ, C3H/HeN, Rag1 2/2 (B6.129S7-Rag1 tm1Mom /J), Fut2 2/2 (B6.129X1-Fut2 tm1Sdo /J), Villin-Cre (B6.SJL-Tg(Vil-Cre)997Gum/J), and CD11c-Cre (C57BL/6J-Tg(Itgax-Cre,-EGFP)4097Ach/J) mice were purchased from The Jackson Laboratory. Fut2 2/2 mice were backcrossed greater than seven generations to BALB/c. Knockout mice produced litters of mixed genotypes kept cohoused to homogenize their gut microbiota. B6 Myd88 2/2 mice were a gift from S. Akira. B6 MyD88 floxed mice were described previously 31 . Rorc 2/2 (ref. 32) , and IL23p19 2/2 (also known as Il23a 2/2 ) 33 mice were provided by Y.-X. Fu. Il22 2/2 mice 34 were maintained at the Memorial Sloan-Kettering Cancer Center. Mice were housed in a specific pathogen-free facility and used in accordance with institutional guidelines for animal welfare. Six-to twelve-week-old male and female mice were used for randomization purposes. The numbers of mice per group were chosen as the minimum needed to obtain biologically significant results, based on previous experience. Evaluations were made in a blind fashion. Functional experiments were done with Fut2-negative mice on the BALB/c genetic background using Fut2sufficient littermates as controls. Metabolic studies. Mice were single-housed in TSE Systems LabMaster cages to monitor physical activity (x/y and z axes by infrared beams crossed), drinking and feeding. Fucosylation activation in vivo. LPS from S. enterica ssp. Typhimurium (#L6511, Sigma-Aldrich) was injected i.p. at 1 mg g 21 body weight, or gavaged to GF mice at 1 mg in 400 ml sterile PBS. CpG (100 mg CpG-B ODN 1826, Coley Pharmaceutical Group) and Pam 3 CSK 4 (100 mg, Invivogen), were injected i.p. Carrier-free recombinant mouse IL-22 (Biolegend,) was diluted in 1% BSA/PBS and 1.5 mg was given i.p. Antibiotic treatment. Ampicillin (1 g l 21 ) and 200 mg l 21 vancomycin (Sigma-Aldrich) were 0.22 mm filtered and added to autoclaved drinking water starting 2 days before LPS treatment (day 22) and lasting for the duration of the experiment. Lectin staining. For whole-mount staining, small intestine was removed, a 1 cm piece from the upper third was excised, opened, cleaned of mucus in cold PBS, and incubated with Ulex europaeus aggluitinin-1 (UEA-1) conjugated to FITC, TRITC or atto-594 (Vector Laboratories or Sigma-Aldrich) for 15 min on ice. Tissue was placed lumen side up on a slide for microscopy. For Il22 2/2 experiments, whole tissue was fixed in 4% paraformaldehyde before proceeding with whole-mount staining. Fixation did not affect staining pattern or intensity.
For staining of sections, tissues were fixed in 2% paraformaldehyde overnight at 4 uC, cryoprotected in 20% sucrose/PBS overnight at 4 uC, and embedded in OCT compound (Sakura Finetek), and 10 mm sections were stained with UEA-1-FITC (1 mg ml 21 , Vector) for 30 min at room temperature, and incubated for 20 min at 37 uC in propidium iodide (0.5 mg ml 21 , Sigma-Aldrich) with RNase A (10 mg ml 21 , Sigma-Aldrich) to label nuclei.
For single-cell analysis by FACS, small intestine (with Peyer's patches and mesenteric fat removed) was divided into equal thirds, opened longitudinally and washed with cold PBS. Tissue was cut into 1 cm pieces and shaken in 10 mM EDTA/1 mM dithiothreitol (DTT)/PBS at 37 uC for 20 min, and filtered through nylon mesh. Single-cell suspensions were pelleted and fixed in 5 ml of 1% paraformaldehyde overnight at room temperature. Cells were then stained with UEA-1-FITC (1 mg ml 21 , Vector), and gated on the FSC/SSC high epithelial cell population. Light microscopy. Fluorescence microscopy of whole-mounts and sections used a Leica DM LB microscope (Leica Camera AG) and Spot RT Slider camera and software (Diagnostic Instruments). Confocal microscopy of bacteria was performed with an Olympus DSU spinning disk microscope and Slidebook software (3I). All images in an experiment were taken using the same exposure settings. Scanning electron microscopy. Tissues were fixed in 2% paraformaldehyde/2% glutaraldehyde/0.1 M cacodylate buffer, transferred to cacodylate buffer overnight and processed with the OTOTO procedure 35 . To dehydrate, samples were passed through increasing concentrations of acetone in water, followed by hexamethyldisilazane (Electron Microscopy Sciences). Samples were mounted with colloidal silver paste (Electron Microscopy Sciences) and imaged with an FEI Nova NanoSEM 230 (FEI) at 5 kV. Identification of fucosylated proteins. To visualize fucosylated proteins in the lumen contents, the intestinal contents were gently removed by squeezing and homogenized at 1 g sample per 5 ml of Tris-Triton-X-100 buffer (150 mM NaCl, 50 mM Tris pH 8, 1% Triton X-100, and protease inhibitor tablet (Roche)) on ice and spun at 17,000g for 20 min at 4 uC. Supernatant proteins were separated by 6% nonreducing SDS-PAGE, transferred to PVDF membrane (Bio-Rad), blocked with 0.5% gelatin in 0.05% Tween-20/PBS, and visualized with UEA-1-HRP (1 mg ml 21 , Sigma-Aldrich).
For sequencing of fucosylated epithelial cell proteins, small intestine epithelial cells were isolated as described earlier and lysed in Tris-Triton-X-100 buffer. Lysates were pre-cleared by incubating with unconjugated agarose beads (Vector) twice for 45 min at 4 uC. Cleared lysates were then incubated with washed UEA-1-conjugated beads (Vector) for 45 min. Beads were washed five times to remove unbound protein.
To elute UEA-1-bound protein, beads were incubated with 200 mM L-fucose (Sigma-Aldrich) for 30 min. Eluted proteins were separated on a 4-15% gradient SDS-PAGE gel (Bio-Rad), silver-stained (Thermo Fisher Scientific), and bands were excised for identification by mass spectrometry at the Taplin Biological Mass Spectrometry Facility, Harvard Medical School. Isolation of fucosidase-positive bacteria. Brain heart infusion (BHIS) agar plates (Becton, Dickinson, and Co.) with added thioglycolic acid, menadione and hematin/ histidine (Sigma-Aldrich) were pre-reduced in an anaerobic chamber with 2.5% hydrogen atmosphere at 37 uC, and spread with 40 ml of 5-bromo-4-chloro-3-indolyla-L-fucopyranoside (50 mM in DMF) (Carbosynth). Faecal pellets were homogenized in reduced 0.01% thioglycolic acid/PBS, plated, and grown for 3 days at 37 uC anaerobically, then at 4 uC aerobically to develop colour. Blue colonies were identified by sequencing of their 16S rDNA genes using primers 8F (59-AGAGTTTGATCC TGGCTCAG-39) and 1391R (59-GACGGGCGGTGWGTRCA-39), and sequencing of their gyrB genes using primers gyrB F (59-GAAGTCATCATGACCGTTCTGC AYGCNGGNGGNAARTTYGA-39) and gyrB R (59-AGCAGGGTACGGATGT GCGAGCCRTCNACRTCNGCRTCNGTCAT-39) for amplification and gyrB FS (59-GAAGTCATCATGACCGTTCTGCA-39) and gyrB RS (59-AGCAGGGTAC GGATGTGCGAGCC-39) for sequencing 36 . B. thetaiotaomicron VPI-5482 and B. uniformis (a gift from C. Nagler) were used as controls. Measurement and inhibition of fucosidase activity. Faecal pellets were weighed and homogenized in 10 ml PBS per 1 mg sample, and centrifuged at 17,000g for 10 min. Fifty microlitres of this supernatant was incubated for 1 h at 37 uC with or without adding 0.5 ml of 50 mM 4-methylumbelliferyl fucopyranoside (in dimethylsulphoxide (DMSO), Sigma or Gold Biotechnology). The reaction was diluted 100-fold in 0.2 M glycine-NaOH buffer, pH 10.5, and fluorescence was measured at 365 nm excitation, 445 nm emission. Fluorescence of the no-substrate control was subtracted from the substrate-containing reaction. The amount of cleaved substrate and fucosidase activity was then calculated by comparison to a standard curve of 4-methylumbelliferone (Sigma) in glycine-NaOH buffer. Deoxyfuconojirimycin (DFJ; Enzo Life Sciences) was dissolved in PBS and gavaged to mice in 100 ml (5 mmol total). Reporter E. coli. The pXDC94 plasmid 21 , containing the ptac promoter controlling mCherry expression and a multiple cloning site upstream of the promoter-less GFP gene, was a gift from H. Shuman. The promoter region upstream of the E. coli fucPIK genes 22 was amplified using primers that added restriction sites (bold) at the 59 and 39 ends of the amplicon, respectively: fucproF, 59-TATGGTACCGGAT TCATTTTCAAATAAAA-39; fucproR, 59-TATCCCGGGTAGCTACCTCTCTC TGATTC-39. The PCR product and vector were digested with XmaI and KpnI (New England Biolabs), gel purified, ligated, and introduced into E. coli K-12 strain BW25113 (Yale Coli Genetic Stock Center) by electroporation. Correct expression of mCherry and GFP was verified by growth in minimal medium 37 with 10 mM glucose and the indicated concentrations of fucose.
E. coli K12 bacteria carrying the pXDC94-fucPIK-pro reporter were grown overnight in Luria-Bertani broth (LB) with shaking at 37 uC, centrifuged at 5,000g, resuspended to ,10 9 c.f.u. ml 21 in PBS, and 400 ml gavaged to mice that had received LPS i.p. 6 h earlier (SPF mice), or at the time of gavage (gnotobiotic mice). For dual colonization with B. acidifaciens, 100 ml of stationary-phase culture was gavaged at the same time as E. coli. Twenty-four hours after gavage, mice were killed and their caecum and colon contents were homogenized in PBS. Bacteria were enriched by centrifuging at 200g for 5 min, centrifuging the supernatant at 5,000g for 5 min, and resuspending the pellet in 750 ml PBS. This was underlain with 300 ml Histopaque-1119 (Sigma-Aldrich) and centrifuged for 1 min at 11,600g. The interface containing mostly bacteria was washed with PBS, fixed in 2% paraformaldehyde for 20 min at room temperature, washed and resuspended in 50-100 ml PBS. Four microlitres of bacterial suspension was placed on a slide and coverslipped. Random fields were selected using red fluorescence only, and an image was acquired in both the red and green channels. Fluorescence of individual bacteria were measured in ImageJ 1.41 software 38 by gating on areas of red fluorescence and measuring the mean green pixel intensity within the gated area. Estimation of total bacterial loads. Fresh faecal pellets were placed in an anaerobic chamber and mashed in 500 ml of reduced PBS containing 0.01% thioglycolic acid. Serial dilutions were made in reduced PBS and plated on pre-reduced Brucella blood agar plates (Becton, Dickinson, and Co.; for anaerobic counts), removed from the anaerobic chamber, and plated on tryptic soy agar (TSA)/5% sheep's blood plates (Becton, Dickinson, and Co.; aerobic counts). Total colonies were counted after 2 days (aerobic) or 3 days (anaerobic) incubation at 37 uC.
For 16S copy number, faecal pellets were weighed, DNA was isolated by a bead beating and phenol/chloroform extraction method 39 , and qPCR performed and copy number determined as described 40 . S. enterica Typhimurium and C. rodentium infection. For S. enterica Typhimurium infection, mice were gavaged with 20 mg streptomycin (Sigma) in 100 ml sterile water, 24 h before infection. S. enterica Typhimurium strain SL1344 was grown overnight in LB with streptomycin (50 mg ml 21 ) and gavaged to mice at 5 3 10 8 c.f.u. in 100 ml volume.
C. rodentium strains DBS100 or DBS120 pler-lux were grown in LB overnight at 37 uC, then diluted 1:100 and grown for 2.5 h, centrifuged and resuspended in 0.01 volumes PBS, and mice were gavaged with ,5 3 10 9 bacteria in 100 ml LB. To determine mouse colonization levels, a fresh faecal pellet or small intestine contents (gently squeezed to remove, except last 3 cm of ileum) was weighed, mashed in 500 ml of PBS, serially diluted, and plated on MacConkey (Becton, Dickinson, and Co.) or LB agar with 50 mg ml 21 kanamycin. For luciferase measurements, the faecal homogenate was adjusted to 10 mg in 1 ml PBS in an Eppendorf tube and light measured in a Triathler scintillation counter (Hidex), before plating dilutions in PBS on agar with kanamycin. Colon-adherent bacteria were measured in a 1 cm piece from the middle of the colon. The piece was opened longitudinally, washed in 1 mM DTT/PBS by vortexing for 10 s, then washed in PBS, and placed in an Eppendorf in 500 ml PBS for light measurement as before. The piece was then mashed and dilutions plated on agar with kanamycin. Histology. Distal colon from C. rodentium-infected mice or uninfected controls was fixed in neutral formalin, then kept in 70% EtOH until being embedded in paraffin, and 5 mm sections were cut and stained with haematoxylin and eosin. Well-oriented crypts were photographed and their lengths measured in ImageJ, and the mean taken for each mouse. Serum cytokine ELISA. Serum concentrations were measured by ELISA according to the manufacturer's instructions (IL-1b: eBioscience; IL-6 and TNF-a: Becton, Dickinson and Co.). Short-chain fatty acid measurements. For gavage experiments, food was removed and SPF mice were gavaged at 0, 3 and 6 h with 300 ml of 0.1 M L-fucose or 0.1 M D-galactose (Sigma-Aldrich) in autoclaved tap water, or water only. At 8 h, mice were killed and caecal contents removed and kept at 280 uC until processing.
Concentrations of the short-chain fatty acids in caecal contents were measured using the direct injection gas chromatography-mass spectrometry (GC-MS) method adapted from that described previously [41] [42] [43] .
Caecal contents were extracted in two steps. Deionized water was added to the samples at the amount of 5 ml per 1 g of sample, followed by brief vortex-mixing and sonication for 15 min. In the second step, acetonitrile (#1103, BDH) containing 20 mM of tetradeuteroacetic acid (#16621, Acros Organics) was added to the aqueous extracts at the amount of 5 ml per 1 g of initial sample, followed by the second round of brief vortex-mixing and sonication for 15 min.
Extracted samples were centrifuged for 5 min at 17,000g and 0.02 ml of clear supernatant was mixed with 0.98 ml of acetonitrile containing 20 mM of formic acid (#94318, Fluka) and 0.05 mM of 2-ethylbutyric acid (#109959, Aldrich). The mixtures were briefly vortex-mixed and centrifuged for 5 min at 17,000g and 1 ml of the obtained supernatants were analysed by direct injection GC-MS on an Agilent 6890N GC system equipped with a Mass Selective (MS) Detector 5973 (Agilent Technologies).
The instrument was used in a splitless mode with an installed double taper inlet liner (#23308, Sky by Restek) and fused-silica column with polyethylene glycol stationary phase (INNOWax #19091N-133, J&W Scientific, Agilent Technologies) 30 m 3 0.25 mm ID coated with 0.25 mm film.
Helium carrier gas was supplied at 1.00 ml min 21 flow rate. The injection port temperature was 260 uC. The initial oven temperature of 60 uC was maintained for 2 min, then increased to 150 uC at 10 uC min 21 and further to 250 uC at 25 uC min 21 and held at that temperature for 4 min, bringing the total duration of the run to 19 min. The MS detector temperature was set to 245 uC.
GC-MS data were analysed using the MSD ChemStation D.01.02.16 software (Agilent Technologies). Tetradeuteroacetic and 2-ethylbutyric acids served as internal standards. Enzymatic activity of digestive enzymes. Epithelial cells were dissociated from the upper half of the small intestine as described earlier. Haematopoietic cells were removed with anti-CD45-biotin (clone 30-F11, Biolegend) and streptavidin magnetic beads with a MACS LS column (Miltenyi Biotec). Epithelial cells were diluted in 96-well plates in triplicate in appropriate substrate solutions (for sucrase, 60 mM sucrose in PBS; for maltase, 30 mM maltose in PBS; for aminopeptidase, 5 mM leu-pNA (Enzo Life Sciences) in 50 mM TRIS, pH 7.4). Cells were incubated for 30-60 min at 37 uC. For the aminopeptidase assay, absorbance was measured at 405 nm. For the sucrase and maltase assays, plates were centrifuged and 5 ml of supernatant was used for a colorimetric assay to measure liberated glucose (Cayman Chemical). Metagenomic library preparation and sequencing. Methods for microbial community DNA and mRNA sequencing were as previously described 44, 45 . Faecal pellets collected from mice before or after LPS treatment (pooled from 2 and 3 days post-injection) were kept at 280 uC until DNA and RNA isolation using the guanidinium thiocyanate/caesium chloride gradient method 46 as described, except that crude particles were removed by centrifugation before overlaying the gradient. RNA was subjected to DNase treatment (Ambion), purification using MEGAClear columns (Ambion), and rRNA depletion via subtractive hybridization (MICROBExpress, Ambion, in addition to custom depletion oligonucleotides). The presence of genomic DNA contamination was assessed by PCR with universal 16S rDNA primers. cDNA was synthesized using SuperScript II and random hexamers (Invitrogen), followed by second-strand synthesis with RNaseH and E.coli DNA polymerase (New England Biolabs). Samples were prepared for sequencing with an Illumina HiSeq instrument after enzymatic fragmentation (NEBE6040L/M0348S). Libraries were quantified by qPCR according to the Illumina protocol. qPCR assays were run using ABsoluteTM QPCR SYBR Green ROX Mix (Thermo Scientific) on an Mx3000P QPCR System instrument (Stratagene). The size distribution of each library was quantified on an Agilent HS-DNA chip (Agilent). 16S rRNA gene sequencing and analysis. Community DNA was PCR-amplified using universal bacterial primers targeting variable region 4 of the 16S rRNA gene with the following thermocycler protocol: denature at 94 uC for 3 min, 35 cycles of 94 uC for 45 s, 50 uC for 30 s, and 72 uC for 90 s, with a final extension at 72 uC for 10 min 45, 47, 48 . Triplicate reactions for each sample were pooled and amplification was confirmed by 1.5% gel electrophoresis. 16S rRNA gene amplicons were cleaned with the Ampure XP kit (Agencourt) and quantified using the Quant-iT Picogreen ds DNA Assay Kit (Invitrogen). Barcoded amplicons from multiple samples were pooled and sequenced using the Illumina HiSeq platform 47 . 16S rRNA gene sequences were analysed using the QIIME (Quantitative Insights Into Microbial Ecology) 44 software package along with custom Perl scripts. Data sets were randomly subsampled before clustering analyses at a depth that retained all of the individual samples (180,000 sequences per sample). All sequences were used for the comparison of the relative abundance of bacterial taxonomic groups. OTUs were picked at 97% similarity against the Greengenes database 49 (constructed by the nested_gg_workflow.py QiimeUtils script on 4 February 2011), which we trimmed to span only the 16S rRNA region flanked by our sequencing primers (positions 521-773). The LefSe package was used to identify taxonomic groups significantly associated with each treatment 50 . LefSe was run on the sub-sampled data sets, after filtering out species-level OTUs with ,100 sequences or present in only 1 sample. Statistical analyses were also performed using the QIIME scripts 'otu_category_significance' (ANOVA) and 'compare_ categories.py' (PERMANOVA). Reference genome database. A custom database was constructed from draft and finished reference genomes obtained from human-associated microbial isolates (538 genomes from the Human Microbiome Project Data Analysis and Coordination Center (http://www.hmpdacc.org)), in addition to the Eggerthella lenta DSM2243 reference genome. All predicted proteins from the reference genome database were annotated with KEGG orthologous groups (KOs) using the KEGG database (version 52; BLASTX e-value , 10 25 , bit score . 50, and .50% identity) 51 . For query genes with multiple matches, the annotated reference gene with the lowest e-value was used. When multiple annotated genes with an identical e-value were encountered after a BLAST query, we included all KOs assigned to those genes. Genes from the database with significant homology (BLASTN e-value , 10 220 ) to non-coding transcripts from the 539 microbial genomes were excluded from subsequent analysis. Metagenomic sequence analysis. DNA-and RNA-seq analysis was performed with our recently described pipeline 45 . Briefly, high-quality reads (see Supplementary  Table 1 for sequencing statistics) were mapped using SSAHA2 52 to our custom 539genome database and the Illumina adaptor sequences (SSAHA2 parameters: '-best 1 -score 20 -solexa'). The number of transcripts assigned to each gene was then tallied and normalized to reads per kilobase per million mapped reads (RPKM). To account for genes that were not detected owing to limited sequencing depth, a pseudocount of 0.01 was added to all samples. Samples were clustered in Matlab (version 7.10.0) based on gene expression or abundance. Genes were grouped by KOs by calculating the cumulative RPKM for each sample for genes present in at least six samples. We used HUMAnN, a recently developed software package for metabolic reconstruction from metagenomic data 53 , followed by LefSe analysis to identify metagenomic biomarkers 50 . A modified version of the ''SConstruct'' file was used to input KO counts into the HUMAnN pipeline for each RNA-seq data set. We then ran LefSe on the resulting KEGG module abundance file using the '-o 1000000' flag. We used the edgeR package 54 to identify orthologous groups with significantly altered abundance or expression. Prior to analysis, we calculated the cumulative number of sequencing reads assigned to each sample for each KO (without RPKM normalization). We then used a paired glm analysis to determine consistent changes within each animal following LPS treatment. Default parameters were used, with one exception: for the estimateGLMTrendedDisp step 'min.n' was set to 50/300 for the genomes and KO, respectively. Significance was accepted at a false discovery rate (FDR) , 0.05 and .2-fold change. PCR and RT-PCR. RNA was isolated from mouse tissues and gut contents by the guanidinium thiocyanate/caesium chloride gradient method 46 . RNA was DNase treated (Sigma) and reverse transcribed with Superscript III (Invitrogen). Primer sequences were as follows: fut1F, 59-CAAGGAGCTCAGCTATGTGG-39, fut1R, 59-GACTGCTCAGGACAGGAAGG-39; fut2F, 59-ACAGCCAGAAGAGCCAT
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Extended Data Figure 4 | Consequences of LPS injection in Fut2-sufficient and Fut2-deficient BALB/c mice. a, Inflammatory cytokines IL-1b, IL-6 and TNF-a were measured by ELISA in sera of mice before or 2 h after injection with LPS (4 h for IL-1b). abx, mice on antibiotic water for 2 days before injection. Bars are mean 6 s.e.m.; ND, not detected. Data are combined from three experiments. b, Expression of RegIIIc (also regulated by the MyD88-IL23-IL22 pathway). Measurement by qPCR of reg3g gene expression in midsmall-intestine tissue, relative to gapdh (ddCt method). Numbers indicate mean fold change 6 s.e.m. in LPS-treated versus untreated mice. Differences between LPS-treated Fut2 1 and abx or Fut2 2 levels are not significant (P . 0.05, two-tailed Student's t-test). Data are combined from three experiments. c, Weight loss and recovery is not different in Fut2 1/2 and Fut2 2/2 mice after simple starvation (mean 6 s.e.m., P . 0.05 at all time points, two-tailed Student's t-test; NS, not significant). d, Lack of direct toxic effect of antibiotics (abx) measured as the weight loss of BALB/c GF animals treated with LPS i.p (mean 6 s.e.m., P . 0.05 by two-tailed Student's t-test at all time points). Data are combined from two experiments. e-g, Similar total bacterial loads in Fut2 1/2 and Fut2 2/2 mice before and after LPS injection and antibiotic treatment. Total bacterial loads in faeces were estimated by plating on aerobic (e) and anaerobic (f) non-selective media, and by qPCR for 16S gene copies (g). There were no significant differences between Fut2-sufficient (filled circles) and Fut2-deficient (open circles) mice before or after LPS treatment (two-tailed Student's t-test). Circles indicate individual mice; horizontal lines indicate means; red circles indicate antibiotic-treated mice. Data are combined from three experiments.
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